Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Influenza neutralizing clones
- Development stage
- Preclinical
- Lead developer
- Kling Biotherapeutics
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
01
Overview
Influenza neutralizing clones is a therapeutic program under development by Kling Biotherapeutics for the treatment and prevention of influenza. The program consists of monoclonal antibodies designed to bind to and neutralize the influenza virus, thereby preventing viral entry into host cells and inhibiting replication. These antibodies are identified using Kling Biotherapeutics' proprietary B-cell screening platform, which isolates naturally occurring, high-affinity antibodies from the immune repertoire of human donors who have successfully cleared infections. The program is currently in the discovery phase, aiming to provide a targeted immunotherapy that can mitigate disease severity and reduce viral spread.
- Other names
- Influenza neutralizing clones
02
Targets
Flu (Influenza surface proteins)
Beyond the preview
Go deeper on Influenza neutralizing clones.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Influenza neutralizing clones.